Atopic dermatitis (AD) is a common inflammatory skin condition affecting 15-30% of the global population, characterized by symptoms such as skin irritation and dryness, and often coexists with other atopic conditions. Its pathophysiology involves genetic, immunological, and environmental factors. AD shares correlations with alopecia areata, including similar intracellular mechanisms and potential treatment overlaps. Treatment requires a personalized approach, integrating nonpharmacological methods and topical or systemic therapies, with topical corticosteroids as the first line for flares. Future treatments may focus on the microbiome and biomarkers for personalized strategies, highlighting the need for individualized management.
1 citations
,
November 2023 in “International journal of molecular sciences” Cannabinoids might help treat skin problems but more research is needed to be sure.
277 citations
,
December 2019 in “Frontiers in Immunology” JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.
19 citations
,
January 2019 in “JAAD case reports” A medication for skin rash also unexpectedly treated hair loss in a patient.
58 citations
,
July 2018 in “Journal of Allergy and Clinical Immunology” Alopecia areata severity is linked to increased TH1 and TH2 activity.
102 citations
,
December 2017 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings” Restoring hair bulb immune privilege is crucial for managing alopecia areata.
355 citations
,
January 2017 in “Journal of the American Academy of Dermatology” JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.
55 citations
,
January 2000 in “Cell biochemistry and function” Alopecia patients have lower antioxidants and higher lipid damage in their blood.